Skip to content
Advertisement

In this image from video provided by C-SPAN, U.S. Drug Enforcement Administration Administrator Anne Milgram speaks during a hearing before the Senate Appropriations Subcommittee on Commerce, Justice, and Science in Washington on May 10, 2023. At center left behind Milgram is Louis Milione. After temporarily leaving the DEA in 2017, like dozens of colleagues in the agency's powerful-but-little-known Office of Diversion Control, Milione immediately went to work as a consultant for some of the same companies he had been tasked with regulating, including Morris & Dickson. He was named deputy administrator in 2021. On another front, a federal watchdog is investigating whether Milgram improperly awarded millions of dollars in no-bid contracts to hire her past associates. (C-SPAN via AP)

In this image from video provided by C-SPAN, U.S. Drug Enforcement Administration Administrator Anne Milgram speaks during a hearing before the Senate Appropriations Subcommittee on Commerce, Justice, and Science in Washington on May 10, 2023. At center left behind Milgram is Louis Milione. After temporarily leaving the DEA in 2017, like dozens of colleagues in the agency's powerful-but-little-known Office of Diversion Control, Milione immediately went to work as a consultant for some of the same companies he had been tasked with regulating, including Morris & Dickson. He was named deputy administrator in 2021. On another front, a federal watchdog is investigating whether Milgram improperly awarded millions of dollars in no-bid contracts to hire her past associates. (C-SPAN via AP)

Featured Photo Galleries